Track market-moving stories before they get noisy

Key Takeaways Ingersoll Rand's Q3 adjusted earnings rose 24.4% to $1.07 per share, beating estimates by 20.2%.Orders jumped 20.7% to $2.35 billion, while free cash flow surged to $623.3 million.IR raised 2026 revenue growth guidance to 5.5-7% and earnings guidance to $3.58-$3.70 per share.
Ingersoll Rand Inc. (IR - Free Report) reported third-quarter 2026 adjusted earnings of $1.07 per share, beating the Zacks Consensus Estimate of 89 cents by 20.2%. The bottom line increased 24.4% from the year-ago quarter.

Revenues of $2.06 billion surpassed the consensus estimate of $2.04 billion by 1.1% and rose 5.6% year over year. Organic revenues increased 3.9%, while acquisitions and favorable foreign currency movements contributed 1.4% and 0.3%, respectively.

IR's Orders and Organic GrowthIn the third quarter of 2026, its total orders increased 20.7% to $2.35 billion. Organic orders increased 18.2% year over year. Acquisitions added 1.7% to order growth, while foreign currency translation contributed 0.8%.

Management noted an improved demand environment and healthy order momentum across short-to-medium-cycle and long-cycle businesses. The company recorded a book-to-bill ratio of 1.14, supported by an approximately $195 million order for a large-scale, mission-critical infrastructure project.

Segmental PerformanceIndustrial Technologies and Services generated revenues of $1.62 billion, up 5.2% year over year and accounting for about 78.5% of total revenues. Organic revenues increased 3.5%, with positive growth across all regions. Acquisitions and foreign currency added 1.2% and 0.5%, respectively. The segment recorded a book-to-bill ratio of 1.17, indicating strong order momentum.

The segment's adjusted EBITDA increased 6.3% to $475.7 million, while its margin expanded 40 basis points to 29.4%. Excluding IEEPA tariff refunds, adjusted EBITDA increased 0.7% to $450.8 million, while the margin contracted 120 basis points to 27.8%. Organic orders surged 22.1%, driven by strength in long-cycle projects and continued momentum in short-to-medium-cycle businesses.

Precision and Science Technologies recorded revenues of $444.9 million, up 7.3%. Organic revenues increased 5.5%, while acquisitions contributed 2.2%. Foreign currency had an unfavorable impact of 0.4%. Organic orders rose 4.2%, supported by low-double-digit growth in Life Sciences Technologies.

The segment's adjusted EBITDA increased 19.5% to $152.5 million. Its adjusted EBITDA margin expanded 350 basis points to 34.3%. Excluding IEEPA tariff refunds, adjusted EBITDA increased 13.7% to $145.1 million, while the margin expanded 180 basis points to 32.6%, reflecting strong operational execution.

Ingersoll Rand's Margin ProfileThe company's total adjusted EBITDA increased 7.3% year over year to $584.4 million. The adjusted EBITDA margin expanded 40 basis points to 28.3%. Excluding IEEPA tariff refunds, adjusted EBITDA increased 1.4% to $552 million, while the margin contracted 120 basis points to 26.7%, primarily due to inflationary pressures.

In the quarter, IR's cost of sales increased 3.7% to $1.14 billion, while selling and administrative expenses rose 8% to $389.7 million. Adjusted net income increased to $416.6 million from $345.6 million, while the adjusted net income margin expanded to 20.2% from 17.7%.

Ingersoll Rand's Cash Flow and LiquidityCash provided by operating activities totaled $647.8 million in the third quarter, up from $354.6 million in the year-ago quarter. Capital expenditures declined to $24.5 million from $29.1 million, lifting free cash flow to $623.3 million from $325.5 million. The free cash flow margin improved to 30.2% from 16.6%.

IR ended the quarter with $3.9 billion in available liquidity, including $1.34 billion in cash and $2.6 billion of undrawn revolving credit capacity. The company paid dividends of $8 million and repurchased shares worth $350 million. It also deployed $90 million toward acquisitions.

Long-term debt (less current maturities) was $4.04 billion, lower than $4.78 billion recorded at the end of 2025. Net debt to adjusted EBITDA improved to 1.6 times from 1.8 times in the year-ago quarter.

IR's 2026 OutlookIngersoll Rand raised its 2026 revenue growth outlook to 5.5-7% from the previous projection of 4.5-6.5%. The forecast assumes organic growth of 2-3.5%, an approximately 1% currency benefit and a roughly 2.5% contribution from acquisitions.

The company maintained its adjusted EBITDA guidance of $2.13-$2.19 billion, excluding third-quarter IEEPA tariff refunds. Management raised its adjusted earnings forecast to $3.58-$3.70 per share from the previous range of $3.45-$3.57.

Free cash flow conversion is projected to exceed 100% of adjusted net income, including recoveries related to the ILC Dover transaction. Excluding these recoveries, free cash flow conversion is projected at approximately 95%.

IR’s Zacks RankThe company currently carries a Zacks Rank #3 (Hold).  

You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Performance of Other CompaniesIn the third quarter of 2026, Graco Inc. (GGG - Free Report) came out with quarterly earnings of $0.81 per share, missing the Zacks Consensus Estimate of $0.82 per share. This compares with earnings of $0.73 per share a year ago.

Graco reported revenues of $586.39 million in the quarter ended September 2026, missing the Zacks Consensus Estimate by 0.58%. This compares with year-ago revenues of $543.36 million.

Dover Corporation (DOV - Free Report) has reported third-quarter 2026 adjusted earnings of $2.88 per share, rising 10% year over year and beating the Zacks Consensus Estimate of $2.83 by 1.77%. The improvement reflected broad-based demand, higher revenues and operational execution.

Revenues increased 7.5% year over year to $2.23 billion, beating the Zacks Consensus Estimate of $2.20 billion by 1.47%. Organic revenues grew 7.1%. Our model expected organic revenues to rise 4%.

Allegion plc (ALLE - Free Report) reported third-quarter 2026 adjusted earnings of $2.60 per share, up 13% year over year. The figure beat the Zacks Consensus Estimate of $2.49 by 4.4%, supported by strong organic growth and margin expansion.

Revenues increased 9.6% year over year to $1.17 billion, beating the Zacks Consensus Estimate of $1.13 billion by 3.4%. Organic revenues grew 7.2%, driven by strength in the Americas non-residential business, volume growth and price realization.

Key Takeaways Cencora is set to report Q4 results on Nov. 4, with earnings expected to rise 18.5% and revenues 5.3%.Specialty pharma demand, OneOncology contributions and international growth are expected to drive Q4 results.Pricing pressures, biosimilar conversions and higher interest expenses could offset Cencora's operating gains. Cencora, Inc. (COR - Free Report) is slated to report fourth-quarter fiscal 2026 results on Nov. 4, before market open.

In the last reported quarter, the company delivered an earnings surprise of 2.52%. COR’s earnings beat estimates in three of the trailing four quarters and missed once, delivering an average surprise of 0.76%.

Cencora’s Q4 EstimatesThe Zacks Consensus Estimate for revenues is pegged at $88.16 billion, up 5.3% from the prior-year quarter’s level. The consensus mark for earnings is pinned at $4.55 per share, indicating an improvement of 18.5% from the prior-year quarter’s figure.

So far this year, COR’s shares have lost 2.2% against the industry’s growth of 11.6%. The S&P Index has gained 11.2% in the same period.

Image Source: Zacks Investment Research

Factors to Consider Before COR’s Q4 ResultsCencora is expected to report another quarter of solid earnings growth in its fiscal fourth-quarter 2026 results, supported by continued strength in specialty pharmaceutical distribution, improving contributions from its management services organizations (MSOs) and growth in international operations. Following a strong fiscal third-quarter performance, management expressed confidence in the company's underlying business momentum and raised its fiscal 2026 adjusted earnings per share guidance to $17.75-$17.95. The fourth quarter is expected to have benefited from the full-year contribution of OneOncology, the lapping of the previous oncology customer loss and easier expense comparisons.

Within the U.S. Healthcare Solutions segment, specialty pharmaceutical distribution is likely to have remained a key growth driver. Continued strength in health systems and physician practices, alongside resilient demand for oncology and retina therapies, is likely to have supported segment performance. OneOncology and Regional Cancer Care Associates (RCA) are expected to have continued contributing to operating income growth, with both businesses performing ahead of management's expectations in the fiscal third quarter. Improving physician utilization trends and continued physician additions across the MSO platforms are likely to have provided further support. Moreover, management expects the U.S. segment to deliver its strongest organic operating income growth of fiscal 2026, excluding OneOncology, in the fiscal fourth quarter.

However, U.S. revenue growth is likely to have remained affected by manufacturer list-price reductions, branded-to-biosimilar conversions and lower sales to a large mail-order customer. In the fiscal third quarter, manufacturer price reductions represented a $2.4 billion headwind to revenue growth, partly offset by a $2.3 billion year-over-year increase in GLP-1 sales. While continued growth in specialty drug volumes and GLP-1 demand should have supported revenues, these pricing and customer-mix dynamics are expected to have remained important factors. The growing adoption of Part B biosimilars, meanwhile, presents a longer-term opportunity, given Cencora's distribution, group purchasing organization and physician-support capabilities.

The International Healthcare Solutions segment is expected to have maintained healthy operating momentum, supported by continued strength in European pharmaceutical distribution, World Courier and European third-party logistics (3PL) operations. In the fiscal third quarter, the segment delivered 21% reported operating income growth, with World Courier and European 3PL both generating double-digit operating income growth. Strong contract renewals, new business wins and improving demand in specialty logistics are likely to have supported fiscal fourth-quarter performance. However, the benefit from the timing of manufacturer price increases in a developing-market country, which supported European distribution in previous quarters, is not expected to have repeated in the fiscal fourth quarter, potentially moderating the segment's growth.

Operating profitability is likely to have remained supported by a favorable specialty business mix, continued MSO contributions and productivity improvements. Cencora's digital transformation initiatives, including the use of artificial intelligence in demand forecasting, are also expected to have supported operational efficiency, improved product availability and streamlined business processes in the fiscal fourth quarter. However, higher interest expense associated with the debt raised to finance the OneOncology acquisition is likely to have weighed on earnings. The company has made progress in reducing acquisition-related debt, having fully repaid the $800 million RCA financing-related term loan balance by July 2026.

Earnings Beat UnlikelyOur proven model does not predict an earnings beat for COR this earnings season. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the chances of an earnings beat, which is not the case here.

Earnings ESP:Earnings ESP, which represents the difference between the Most Accurate Estimate and the Zacks Consensus Estimate, is +0.66%. You can uncover the best stocks to buy or sell before they are reported with our Earnings ESP Filter.

Zacks Rank:The company carries a Zacks Rank #4 (Sell) at present.

Stocks Worth a LookHere are some medical stocks worth considering, as these have the right combination of elements to post an earnings beat this time:

Phibro Animal Health (PAHC - Free Report) has an Earnings ESP of +2.10% and a Zacks Rank #1. The company is expected to release first-quarter fiscal 2027 results soon.

PAHC’s earnings surpassed estimates in each of the trailing four quarters, the average surprise being 18.4%. The Zacks Consensus Estimate for the company’s first-quarter EPS indicates an increase of 8.2% from the year-ago quarter’s figure.

IDEXX Laboratories (IDXX - Free Report) has an Earnings ESP of +0.59% and a Zacks Rank #2. The company is slated to release third-quarter 2026 results on Nov. 2.

IDXX’s earnings beat estimates in each of the trailing four quarters, the average surprise being 5.7%. The Zacks Consensus Estimate for the company’s third-quarter EPS implies an increase of 9.1% from the year-ago quarter’s figure.

Becton, Dickinson and Company (BDX - Free Report) or BD has an Earnings ESP of +3.28% and a Zacks Rank #2. The company is due to release fourth-quarter fiscal 2026 results on Nov. 5.

BD’s earnings surpassed estimates in each of the trailing four quarters, the average surprise being 2.94%. The Zacks Consensus Estimate for the company’s fourth-quarter EPS calls for a rise of 2.5% from the year-ago quarter’s figure.

Key Takeaways AJG's adjusted earnings rose 29.9% to $3 per share, narrowly missing estimates as revenues fell short. Brokerage organic revenues grew 5%, while adjusted EBITDAC increased 25.3% and margins expanded 200 bps. AJG posted its 26th consecutive quarter of double-digit adjusted EBITDAC growth, with stronger retention. Arthur J. Gallagher & Co. (AJG - Free Report) reported third-quarter 2026 adjusted earnings of $3 per share, missing the Zacks Consensus Estimate of $3.01 by 0.3%. The bottom line increased 29.9% year over year.

Revenues of $3.91 billion also missed the consensus estimate of $3.96 billion by 1.3%. Reported revenues before reimbursements rose 18.2% year over year to $3.93 billion, driven by acquisitions and organic growth. Combined Brokerage and Risk Management organic revenues increased 5%.

AJG's Revenue Mix Reflects Broad-Based GrowthCommissions climbed 24.3% year over year to $2.37 billion, while fees advanced 15.7% to $1.22 billion. Supplemental revenues increased 26.5% to $148 million, while contingent revenues declined 1.3% to $74 million.

Interest income, premium finance revenues and other income declined 32.3% to $113 million. The prior-year quarter benefited from interest earned on cash proceeds associated with the AssuredPartners financing.

Arthur J. Gallagher's Brokerage Business Delivers GrowthBrokerage revenues increased 18.9% year over year to $3.47 billion. Organic commissions, fees, supplemental and contingent revenues increased 5%, reflecting 4% growth in organic base commissions and fees and a 14% increase in organic supplemental revenues.

Organic contingent revenues remained flat. During the quarter, the segment completed five acquisitions with estimated annualized revenues of $102 million compared with six acquisitions and $3.04 billion of annualized revenues acquired a year earlier.
Adjusted Brokerage EBITDAC increased 25.3% to $1.22 billion. EBITDAC represents earnings before interest, taxes, depreciation, amortization and changes in estimated acquisition earnout payables.

The adjusted EBITDAC margin expanded 200 basis points to 35.3%. The improvement reflected AssuredPartners integration benefits, compensation savings and operating expense efficiencies, partially offset by lower interest income.

AJG's Risk Management Results Show StrengthRisk Management revenues before reimbursements increased 13.7% year over year to $457 million. Reported fees rose to $448 million from $393 million, while organic fees advanced 10%.

The segment did not complete any acquisitions during the quarter, consistent with the prior-year period. Adjusted EBITDAC improved 16.9% to $104 million, while the adjusted margin expanded 90 basis points to 22.8%.

The adjusted compensation expense ratio declined 110 basis points to 58.6%, benefiting from headcount controls and lower employee benefits costs.

However, the adjusted operating expense ratio increased 20 basis points to 18.6%, primarily reflecting additional investments in technology.
Gallagher's Expenses Rise, but Profitability Improves.

Total expenses increased 14.6% year over year to $3.46 billion. Compensation expenses rose 15.8% to $2.24 billion, while operating expenses increased 11% to $645 million.

Amortization increased 31.1% to $291 million, reflecting acquired intangible assets. Interest expenses climbed 4.3% to $168 million, while depreciation increased 7.4% to $58 million.

Reported net earnings surged 48.7% to $406 million, while diluted GAAP earnings increased to $1.55 per share from $1.04. Total-company adjusted EBITDAC advanced 23.7% to $1.25 billion.

The effective tax rate increased slightly to 21.2% from 21.1%. Corporate EBITDAC improved to a negative $89 million from a negative $109 million in the year-ago quarter.

AJG's Balance Sheet and Capital ReturnsArthur J. Gallagher ended the quarter with total assets of $79.06 billion, up 11.9% from year-end 2025. Cash and cash equivalents were $1.21 billion, while total stockholders' equity increased 3.1% to $24.07 billion.

Corporate-related borrowings totaled $12.74 billion, including $1.01 billion classified as current. Gallagher also had $228 million of premium financing debt.

During the quarter, AJG repurchased approximately 0.4 million shares for around $100 million. The company declared dividends of 70 cents per share, up from 65 cents in the year-ago quarter.

Gallagher's Organic Growth Supports Business MomentumManagement highlighted strong client retention, new business generation and continued expansion in clients' businesses as important contributors to quarterly performance.

The combined Brokerage and Risk Management segments delivered 25% growth in net earnings and adjusted EBITDAC. This marked the company's 26th consecutive quarter of double-digit adjusted EBITDAC growth, accompanied by margin expansion.

Management also emphasized growing demand for advice, advocacy, analytics and market access as risks become increasingly complex. The company continues to pursue organic expansion alongside acquisitions to support its diversified growth strategy.

Zacks RankPerformance of Other Brokerage InsurersWillis Towers Watson Public Limited Company (WTW - Free Report) reported third-quarter 2026 adjusted earnings of $3.63 per share, beating the Zacks Consensus Estimate of $3.60 by 0.8%. The bottom line increased 18% year over year. Revenues rose 8% to $2.46 billion but missed the consensus estimate of $2.47 billion by 0.4%. Organic revenues grew 4%, supported by growth across both operating segments.

Reported revenues increased from $2.29 billion in the prior-year quarter. Excluding foreign-currency movements, revenues advanced 8%. Acquisitions and divestitures contributed 4 percentage points to the quarterly revenue change. Adjusted EBITDA increased 12% year over year to $577 million. The related margin expanded 100 basis points to 23.5%, reflecting improved underlying profitability.

Brown & Brown, Inc.’s (BRO - Free Report) third-quarter 2026 adjusted earnings of $1.07 per share missed the Zacks Consensus Estimate by 0.9%. The bottom line increased 1.9% year over year. Revenues of $1.72 billion missed the consensus mark by 2.3% but increased 7.4% year over year on a reported basis. Acquisition activity supported the top line, while organic revenues increased 1.2%.

Commissions and fees increased 9.7% year over year to $1.70 billion, while investment and other income declined 55.4% to $25 million from $56 million. Adjusted EBITDAC margin contracted 200 basis points (bps) to 34.6%. Adjusted EBITDAC increased 1.7% to $597 million, while adjusted income before taxes rose 1.3% to $479 million.

Aon plc (AON - Free Report) reported third-quarter 2026 adjusted earnings of $3.36 per share, which surpassed the Zacks Consensus Estimate by 0.6%. The bottom line advanced 10% year over year. Total revenues of $4.1 billion grew 3% year over year. The top line beat the consensus mark by 0.6%. Organic revenue growth was 6%.

Total operating expenses increased 3% year over year to $3.3 billion. The metric exceeded our estimate of $3.2 billion. Adjusted operating income amounted to $1.1 billion, up 5% year over year and in line with our estimate. Adjusted operating margin improved 70 basis points year over year to 27%.

Key Takeaways Tenet's Q3 adjusted EPS surged 79.5% to $6.64, while net operating revenues rose 6.5% to $5.63B.THC raises 2026 adjusted EBITDA guidance to $5.05-$5.20B, aided by $147M in Q3 Conifer transition benefits.Tenet's hospital adjusted admissions rose 3.2%, while USPI's EBITDA climbed 9.1% on higher-acuity care.
Tenet Healthcare Corporation (THC - Free Report) emphasized operational efficiency, higher-acuity services and ambulatory expansion during its third-quarter 2026 earnings call. Management raised its full-year outlook, supported by strong underlying performance and benefits from contract transition activities.

Executives also addressed declining health insurance exchange enrollment, reimbursement uncertainty and opportunities to improve hospital productivity. The discussion highlighted Tenet's focus on sustaining profitability while expanding its surgical care network.

THC Q3 Earnings Beat Estimates on Revenue GrowthTenet reported third-quarter adjusted earnings of $6.64 per share, surpassing the Zacks Consensus Estimate of $4.6. Earnings increased 79.5% year over year from $3.7 per share.

Net operating revenues increased 6.5% to $5.63 billion, exceeding the Zacks Consensus Estimate of $5.47 billion. GAAP earnings rose to $12.41 per share from $3.86 a year earlier.

Consolidated adjusted EBITDA increased 23.3% to $1.36 billion, with margin expanding 330 basis points to 24.1%. Results included a $147 million favorable benefit from Conifer contract transition activities.

Tenet Raises Outlook but Flags 2027 AdjustmentsChairman and chief executive officer Saum Sutaria raised full-year adjusted EBITDA guidance to $5.05-$5.2 billion, representing a $195 million increase at the midpoint.

Chief financial officer Sun Park projected 2026 revenues of $22.05-$22.45 billion and adjusted earnings of $22.05-$23.01 per share. Adjusted free cash flow guidance increased to $2.825-$3.125 billion.

Sutaria expects adjusted EBITDA growth in 2027 after excluding $450 million of nonrecurring Conifer transition benefits recognized in 2026. Management continues assessing exchange enrollment and Medicaid policy risks.

THC Ambulatory Growth Benefits From Higher-Acuity CareUnited Surgical Partners International (USPI) generated adjusted EBITDA of $537 million, increasing 9.1% year over year.

Same-facility revenues increased 4.5%, supported by 6.1% higher revenue per case, despite a 1.5% decline in surgical case volumes. Total joint replacements increased 12.8%.

Responding to Deutsche Bank, Sutaria identified orthopedics, urology, spine and advanced robotics as important growth opportunities. Management continues pursuing acquisitions, partnerships and new surgical centers.

Tenet Hospital Margins Improve Despite Payer PressureHospital adjusted admissions increased 3.2%, while segment adjusted EBITDA reached $818 million.

Park highlighted sustained expense management and technology-enabled productivity improvements. Exchange admissions and revenues declined 18%, creating an unfavorable payer mix.

During questioning from Guggenheim, Park emphasized favorable commercial contract renewals, generally ranging from 3% to 5%. More than 90% of next year's commercial contracts were already secured.

THC Addresses Conifer's Nonrecurring BenefitsThe accelerated transition of CommonSpirit revenue cycle management services contributed $147 million to third-quarter adjusted EBITDA.

Park explained that $97 million reflected revenue recognition timing, while approximately $50 million came from transition-related efficiencies.

Responding to Leerink Partners, Park clarified that the timing benefit shifted revenue from the fourth quarter into the third. Management expects the broader $450 million transition contribution to create a comparison headwind in 2027.

Tenet Prioritizes Cash Flow and Shareholder ReturnsTenet generated $1.10 billion in third-quarter adjusted free cash flow, bringing year-to-date adjusted free cash flow to $2.52 billion.

Management repurchased $1.615 billion of shares during the first nine months. Net debt to adjusted EBITDA declined to 2.11 times.

Park identified ambulatory acquisitions, hospital investments, share repurchases and debt management as capital allocation priorities. Management emphasized maintaining financial flexibility alongside growth investments.

THC Maintains Focus on Sustainable OperationsManagement's overarching message emphasized operating discipline, higher-acuity services and continued expansion of the ambulatory platform.

Sutaria expressed confidence in Tenet's underlying growth prospects while acknowledging reimbursement uncertainty and the need to offset nonrecurring benefits when assessing 2027 performance.

What Zacks Rank and Style Scores Indicate for THCTHC currently carries a Zacks Rank #3 (Hold), indicating a neutral near-term earnings estimate revision outlook under the Zacks framework. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

The stock holds a Value, Momentum and VGM Score of A, alongside a Growth Score of B. These favorable Style Scores reflect attractive characteristics across valuation, growth and momentum measures.

However, the Zacks Rank #3 provides a more balanced signal than the top-ranked stocks typically favored by the combined Zacks framework. The Rank can change as analysts revise earnings estimates following the latest quarterly results.

Key Takeaways Trane raised its 2026 organic revenue growth outlook to 11% but retained EPS guidance at $15.20-$15.30.TT's backlog surged 73% to $12.5B, supported by 20% organic bookings growth and robust HVAC demand.Trane cut its 2026 operating leverage outlook to the low-20% range amid inflation and weaker pricing. Trane Technologies plc (TT - Free Report) raised its 2026 revenue outlook following strong commercial HVAC bookings and resilient residential demand. However, management acknowledged mounting supply-chain costs, inflationary pressures and weaker pricing that constrained operating leverage.

The company reported adjusted earnings of $4.86 per share, beating the Zacks Consensus Estimate of $4.74. Revenues of $6.76 billion surpassed the consensus estimate of $6.44 billion, supported by 16% organic growth.

TT Raises Revenue Outlook but Retains Earnings GuidanceChief financial officer Christopher Kuehn increased the full-year organic revenue growth outlook to 11%, while reaffirming adjusted earnings guidance of $15.20-$15.30 per share.

For the fourth quarter, Kuehn expects mid-teens organic revenue growth and adjusted earnings of $3.40-$3.50 per share. The earnings projection includes a 10-cent tax headwind reversing a third-quarter benefit.

Management reduced its full-year organic operating leverage expectation to the low-20% range from at least 25%, citing weaker pricing, supply-chain disruptions and inflation.

Trane's Backlog Strengthens Visibility Into 2027Chairman and chief executive officer David Regnery highlighted 20% organic bookings growth, supported by strong commercial HVAC demand and global applied equipment orders exceeding 40% growth.

The company's backlog reached $12.5 billion, increasing 73% year over year. During questioning from Wells Fargo, Kuehn disclosed that more than $8 billion relates to 2027 and beyond.

Addressing Citi and UBS analysts' concerns about slowing sequential orders, Regnery emphasized the timing of large data center projects. He highlighted an expanding project pipeline rather than deterioration in underlying demand.

TT Faces Supply-Chain & Pricing ChallengesKuehn lowered the full-year price realization expectation to 1 percentage point from 1.5 points, primarily reflecting timing and customer mix in shorter-cycle businesses.

During questioning from Melius Research, Regnery described disruptions involving motors, drives and other components. Regulatory changes affecting a lower-tier supplier also created manufacturing interruptions and rework costs.

Management expects broader supplier capacity constraints to improve through the first half of 2027. Kuehn maintained the company's long-term operating leverage framework of at least 25%, supported by pricing and productivity initiatives.

Trane's Americas Businesses Drive ExpansionRegnery reported low-20% organic revenue growth in Americas commercial HVAC, including more than 60% growth in Applied Solutions. Americas services revenues increased 10%.

Residential bookings and organic revenues each rose approximately 20%, exceeding management expectations. Regnery raised the full-year residential outlook while emphasizing normalized channel inventory entering 2027.

Americas Transport bookings increased in the high-30% range. Responding to Oppenheimer, Regnery expressed confidence in improving transport demand, although the recovery's pace remains dependent on industry capacity.

TT Sees Regional Growth but Uneven ProfitabilityEMEA organic bookings increased 41%, supported by commercial HVAC demand. However, the adjusted operating margin declined 250 basis points amid continued Middle East disruptions.

Responding to Goldman Sachs, Kuehn attributed more than 80% of EMEA's year-over-year operating income decline to the Middle East conflict.

The Asia Pacific organic bookings increased 21%, although the adjusted operating margin contracted 390 basis points. Regnery highlighted strong demand outside China, where market conditions continued to pressure performance.

Trane Advances Data Center & Acquisition StrategyRegnery emphasized opportunities in advanced thermal management and modular cooling systems, supported by growing data center infrastructure requirements.

Responding to UBS, Kuehn reaffirmed expectations for Stellar to generate $500 million in 2026 revenues, with a longer-term opportunity to reach $1 billion and mid-teens EBITDA margins.

Management also highlighted the planned Cancoil acquisition, which strengthens component supply and heat-transfer capabilities. Kuehn expects capital deployment exceeding $3.4 billion in 2026, including acquisitions, dividends and repurchases.

TT Prioritizes Execution Amid Elevated DemandManagement maintained confidence in long-term commercial HVAC demand, supported by energy efficiency requirements, services growth and a substantial equipment backlog.

Near-term execution remains focused on supplier resilience, pricing recovery and productivity improvements. Regnery and Kuehn emphasized maintaining investment in innovation while addressing margin pressures.

Trane's Zacks Rank & Style ScoresTrane currently carries a Zacks Rank #3 (Hold), indicating a more neutral near-term earnings estimate revision outlook compared with higher-ranked stocks. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Its Growth Score of A and VGM Score of B highlight favorable growth characteristics and a relatively attractive combined style profile. However, the Value Score of C and Momentum Score of D temper that assessment, particularly for momentum-focused investors. The Zacks Rank may change as analysts revise earnings estimates following the latest quarterly results.

Investors in Primoris Services Corporation (PRIM - Free Report) need to pay close attention to the stock based on moves in the options market lately. That is because the Nov. 20, 2026 $37.50 Put had some of the highest implied volatility of all equity options today.

What is Implied Volatility?Implied volatility shows how much movement the market is expecting in the future. Options with high levels of implied volatility suggest that investors in the underlying stocks are expecting a big move in one direction or the other. It could also mean there is an event coming up soon that may cause a big rally or a huge sell-off. However, implied volatility is only one piece of the puzzle when putting together an options trading strategy.

What do the Analysts Think?Clearly, options traders are pricing in a big move for Primoris shares, but what is the fundamental picture for the company? Currently, Primoris is a Zacks Rank #3 (Hold) in the Building Products - Heavy Construction industry that ranks in the Bottom 21% of our Zacks Industry Rank. Over the last 60 days, our Zacks Consensus Estimate for the current quarter has moved from 94 cents per share to 95 cents in that period.

Given the way analysts feel about Primoris right now, this huge implied volatility could mean there’s a trade developing. Oftentimes, options traders look for options with high levels of implied volatility to sell premium. This is a strategy many seasoned traders use because it captures decay. At expiration, the hope for these traders is that the underlying stock does not move as much as originally expected.

ATLANTA, Oct. 30, 2026 (GLOBE NEWSWIRE) -- A shareholder class action lawsuit has been filed against O-I Glass, Inc.(“O-I Glass”) (NYSE: OI). The lawsuit alleges that Defendants made false and misleading statements and/or failed to disclose material adverse facts regarding the progress of O-I Glass’ Fit to Win program. 

If you purchased O-I Glass shares between March 14, 2025, and July 28, 2026, and experienced a loss on that investment, you are encouraged to discuss your legal rights by contacting Corey D. Holzer, Esq. at [email protected], by toll-free telephone at (888) 508-6832, or by visiting the firm’s website at www.holzerlaw.com/case/o-i-glass/ for more information.

The deadline to ask the court to be appointed lead plaintiff in the case is December 28, 2026. 

Holzer & Holzer, LLC, an ISS top rated securities litigation law firm for 2021, 2022, 2023, and 2025, dedicates its practice to vigorous representation of shareholders and investors in litigation nationwide, including shareholder class action and derivative litigation. Since its founding in 2000, Holzer & Holzer attorneys have played critical roles in recovering hundreds of millions of dollars for shareholders victimized by fraud and other corporate misconduct. More information about the firm is available through its website, www.holzerlaw.com, and upon request from the firm. Holzer & Holzer, LLC has paid for the dissemination of this promotional communication, and Corey Holzer is the attorney responsible for its content.  

CONTACT: 
Corey D. Holzer, Esq. 
(888) 508-6832 (toll-free)
[email protected] 

Conagra Brands (CAG) reported earnings 30 days ago. What's next for the stock?

On its third-quarter 2026 earnings call, held on Oct. 22, 2026, Oceaneering (OII -2.86%) announced consolidated adjusted earnings before interest, taxes, depreciation, and amortization, or EBITDA, of $119 million. This result marks the company's highest quarterly operational profit since late 2015. Favorable pricing power and project mix driven by offshore demand expanded earnings.

Management highlighted three key takeaways that support the company's long-term outlook.

1. Subsea Robotics Segment Achieves Highest Margins Since 2020The Subsea Robotics division, or SSR, which operates remote-controlled subsea vehicles, expanded profitability through improved pricing in international markets. This pricing power drove higher profit margins across deepwater drilling regions.

SSR delivered increased revenue, operating income and EBITDA margin with the latter reaching its highest level since we resegmented our businesses in 2020.
-- Roderick Larson, President and Chief Executive Officer2. Aerospace and Defense Expansion Relies on Organic StrengthsManagement is expanding the Aerospace and Defense Technologies segment, or ADTech, which provides government engineering services, by leveraging internal certifications. Instead of overpaying for defense acquisitions, the company relies on established operational expertise.

We've been on the government side more than 40 years, so it's not like we're new to the game. We don't need to buy presence, so to speak.
-- Roderick Larson, President and Chief Executive Officer3. Customer Budget Visibility Shapes the 2027 Financial OutlookManagement established initial projections for 2027 while evaluating the timing of customer offshore spending. Full operational visibility will increase as offshore clients finalize their annual capital budgets.

As we move through the planning cycle and our customers finalize their 2027 budgets, we expect to gain greater visibility into activity levels and the timing of opportunities across our businesses.
-- Roderick Larson, President and Chief Executive OfficerLooking AheadGlobal deepwater offshore markets are strengthening, and management isn't hiding its optimism regarding future industry demand. The business maintains structural advantages in subsea robotics market share, long-standing defense contracts, and specialized offshore engineering. Management is watching customer budget finalizations, project execution schedules, and regional rig relocations.

Looking ahead to 2027, the outlook for global deepwater markets remains constructive, with industry forecasts pointing to higher spending and activity.
-- Roderick Larson, President and Chief Executive OfficerFree cash flow generation and disciplined capital allocation remain central to driving long-term shareholder value.

Our priorities remain disciplined execution, cash generation, and maintaining financial flexibility to support our longer-term objectives.
-- Roderick Larson, President and Chief Executive OfficerThe Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.

Key Takeaways Revvity is set to report Q3 earnings on Nov. 3, with EPS expected to rise 9.3% on 0.3% revenue growth.Strong HCS demand, recovering pharma spending and a Signals software rebound may boost Life Sciences.Diagnostics strength and efficiency gains may aid RVTY, while weak academic spending and TB pressures. Revvity, Inc. (RVTY - Free Report) is slated to report third-quarter 2026 results on Nov. 3, before market open. The company's performance is likely to reflect continued strength in Diagnostics and improving momentum in Life Sciences, supported by recovering pharma and biotech spending, robust demand for high-content screening (HCS) instruments and a return to double-digit growth in Signals software. However, persistent weakness in academic and government spending and continued latent TB-related pressures could weigh on performance.

In the last reported quarter, the company delivered an earnings surprise of 14.6%. RVTY’s earnings beat estimates in each of the trailing four quarters, delivering an average surprise of 6.6%.

Year to date, RVTY’s shares have rallied 71.3%, outperforming the industry’s growth of 9.9% and the S&P Index’s rise of 12.4%.

Image Source: Zacks Investment Research

Q3 EstimatesThe Zacks Consensus Estimate for third-quarter revenues is pegged at $700.9 million, indicating growth of 0.3% from the prior-year quarter’s level. The consensus mark for earnings is pinned at $1.29 per share, indicating an improvement of 9.3% year over year.

Factors Likely to Drive Revvity's Q3 PerformanceRevvity's third-quarter results are expected to have benefited from resilience in its core Life Sciences and Diagnostics businesses, improving demand across its pharma and biotech customer base, which has shown signs of recovery since early 2026.

The Life Sciences segment may have gained momentum from stronger instrument shipments and improving software growth. HCS instruments are likely to have seen robust demand, supported by a strong backlog. Management expects instrument revenues to grow at a mid-single-digit rate in the third quarter. Reagent sales are also likely to have benefited from the fulfillment of larger orders deferred from the second quarter, supporting the upper end of low-single-digit growth.

Signals software is likely to have returned to high-teens organic growth in the third quarter, following a 20% decline in the second quarter due to difficult comparisons and contract timing. Advanced Persistent Virtual revenue and annual recurring revenue momentum are likely to have provided additional support. Recent AI-focused launches, including Signals AI, Xynthetica and the Anthropic connector, are likely to have strengthened customer engagement, although their revenue contribution may have remained relatively modest.

The Diagnostics segment is likely to have remained a key growth contributor, supported by sustained strength in reproductive health and immunodiagnostics. Newborn screening demand, broader portfolio adoption and geographic expansion may have supported reproductive health, although growth is likely to have moderated to low-single digits in the second half. Immunodiagnostics is likely to have benefited from healthy demand for rare autoimmune testing, particularly in the United States, while latent TB-related pressures may have remained a headwind.

Revvity's operational efficiency initiatives are expected to support profitability, with management anticipating benefits beginning in the third quarter. The company expects approximately 29% adjusted operating margins, alongside organic growth of 4-6% and revenues of $685-$700 million. However, softness in academic and government spending and macroeconomic uncertainty may have limited improvement.

What the Zacks Model Unveils for RVTYOur proven model predicts an earnings beat for Revvity this time around. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the chances of an earnings beat, which is exactly the case here.

Revvity's Earnings ESP: Earnings ESP, which represents the difference between the Most Accurate Estimate and the Zacks Consensus Estimate, is +1.03% for RVTY. You can uncover the best stocks to buy or sell before they're reported with our Earnings ESP Filter.

Zacks Rank of Revvity: The company carries a Zacks Rank #2 at present.

Other Stocks Worth a LookHere are some other medical product stocks worth considering, as these too have the right combination of elements to post an earnings beat this reporting cycle.

Phibro Animal Health (PAHC - Free Report) has an Earnings ESP of +2.10% and carries a Zacks Rank #2 at present. The company is set to release first-quarter fiscal 2027 results on Nov. 5. You can see the complete list of today’s Zacks #1 Rank stocks here.

PAHC’s earnings surpassed estimates in each of the trailing four quarters, the average surprise being 18.4%. The Zacks Consensus Estimate for the company’s first-quarter EPS indicates an increase of 8.2% from the year-ago quarter’s figure.

IDEXX Laboratories (IDXX - Free Report) currently has an Earnings ESP of +0.59% and a Zacks Rank #2. The company is slated to release third-quarter 2026 results on Nov. 2.

IDXX’s earnings beat estimates in each of the trailing four quarters, the average surprise being 5.7%. The Zacks Consensus Estimate for the company’s third-quarter EPS implies an increase of 9.1% from the year-ago quarter’s figure.

Becton, Dickinson and Company (BDX - Free Report) , or BD, currently has an Earnings ESP of +0.21% and a Zacks Rank #2. The company is scheduled to release fourth-quarter fiscal 2026 results on Nov. 5.

BD’s earnings surpassed estimates in each of the trailing four quarters, the average surprise being 2.9%. The Zacks Consensus Estimate for the company’s fourth-quarter EPS calls for a rise of 2.5% from the year-ago quarter’s figure.

Key Takeaways Howmet Aerospace's Q3 earnings rose 54% to $1.46 per share, beating estimates by 6.6%.Revenues climbed 29% to $2.70 billion, driven by strong aerospace and gas turbine demand.Howmet Aerospace raised 2026 guidance and expects 2027 revenues of approximately $11.5 billion. Howmet Aerospace Inc. (HWM - Free Report) reported third-quarter 2026 adjusted earnings of $1.46 per share, up 54% year over year. The figure beat the Zacks Consensus Estimate of $1.37 by 6.6%.

Revenues of $2.70 billion increased 29% year over year and surpassed the consensus mark of $2.59 billion by 4.2%. Organic growth was 25%, supported by strong commercial aerospace, defense aerospace and gas turbine demand. Gas turbine revenues surged 45%, while commercial aerospace revenues increased 32%.

HWM's Aerospace and Gas Turbine Markets Drive GrowthCommercial aerospace revenues rose 32% year over year and represented 54% of total revenues. Growth reflected stronger demand for aircraft engine components and spare parts, supported by increasing aircraft production activity.

Gas turbine revenues advanced 45% and accounted for 13% of total revenues. Defense aerospace revenues increased 10%, while commercial transportation revenues rose 28%. Other-market revenues grew 48%. Management highlighted strengthening gas turbine demand and increasing customer volume requirements.

Howmet Aerospace's Engine Products Posts Strong GainsEngine Products generated revenues of $1.45 billion, accounting for 53.7% of consolidated revenues. Segment revenues increased 33% year over year, driven by commercial aerospace and gas turbine demand, including higher demand for engine spare parts.

Segment adjusted EBITDA climbed 57% to $567 million. The adjusted EBITDA margin expanded 580 basis points to 39.1%. Howmet Aerospace added approximately 520 net employees in the segment during the quarter to support expected revenue growth.

HWM's Fastening Systems Benefits From AcquisitionsFastening Systems revenues increased 41% year over year to $630 million, representing 23.3% of total revenues. Results benefited from commercial and defense aerospace growth as well as contributions from the CAM and Brunner acquisitions. Excluding acquisitions, revenues increased 10%.

Segment adjusted EBITDA rose 34% to $185 million. However, the adjusted EBITDA margin contracted 140 basis points to 29.4%, reflecting the impact of the CAM acquisition. The segment continued benefiting from stronger demand across its aerospace markets.

Howmet Aerospace's Other Segments Show Mixed TrendsEngineered Structures revenues declined 4% to $295 million, primarily due to the divestiture of the Savannah disk forging facility. Excluding the divestiture, organic revenues increased 8%. Segment adjusted EBITDA rose 9% to $70 million, while the margin expanded 290 basis points to 23.7%, benefiting from the exit of lower-margin business and product rationalization.

Forged Wheels revenues climbed 32% to $327 million, driven by higher commercial transportation volumes and increased aluminum cost pass-through. Segment adjusted EBITDA increased 18% to $86 million. However, the margin contracted 330 basis points to 26.3%, reflecting the impact of higher aluminum cost pass-through.

HWM's Margin Expansion Supports ProfitabilityAdjusted EBITDA increased 43% year over year to $879 million. The adjusted EBITDA margin expanded 310 basis points to 32.5%, supported by growth across commercial aerospace, defense aerospace, gas turbines and commercial transportation markets.

Adjusted operating income rose 45% to $786 million. The adjusted operating margin improved 320 basis points to 29.1%. On a GAAP basis, operating income increased 43% to $777 million, while the operating margin expanded 280 basis points to 28.7%.

Howmet Aerospace's Cash Flow Backs Capital DeploymentHowmet Aerospace generated $709 million in cash from operations during the quarter, up 34% year over year. Capital expenditures were $147 million, resulting in free cash flow of $562 million, up 33% year over year. The company ended the quarter with a cash balance of $508 million.

The company repurchased $500 million of common stock during the quarter, bringing year-to-date repurchases to $1.1 billion. It also paid down $60 million of debt and increased its quarterly dividend 17% to 14 cents per share. On Oct. 28, the board authorized an additional $5 billion in share repurchases, raising the total authorization to approximately $5.4 billion.

HWM Raises 2026 GuidanceFor the fourth quarter of 2026, HWM expects revenues of $2.74-$2.76 billion. Adjusted EBITDA is projected between $895 million and $905 million, while adjusted earnings are expected in the range of $1.49-$1.51 per share.

For 2026, Howmet Aerospace raised its revenue outlook to $10.29-$10.31 billion. Adjusted EBITDA is now anticipated between $3.325 billion and $3.335 billion, with adjusted earnings projected at $5.49-$5.51 per share. Free cash flow is expected in the range of $1.95-$2.05 billion.

The company also introduced its 2027 revenue outlook of approximately $11.5 billion, representing expected growth of about 12% year over year.

HWM’s Zacks RankThe company currently sports a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

Other Stocks to ConsiderSome other top-ranked stocks are discussed below.

RTX Corporation’s (RTX - Free Report) third-quarter 2026 adjusted earnings per share (EPS) of $2.26 beat the Zacks Consensus Estimate of $1.78 by 27%. The bottom line improved 32.9% from the year-ago quarter’s level of $1.70.

Revenues rose 11.1% year over year to $24.97 billion and beat the consensus mark of $24.01 billion by 4%. Growth was supported by higher commercial aftermarket and defense demand.

Northrop Grumman Corporation (NOC - Free Report) reported third-quarter 2026 adjusted earnings of $7.89 per share, which beat the Zacks Consensus Estimate of $7.22 by 9.3%. The bottom line also increased 2.9% from the year-ago quarter’s level of $7.67.

NOC’s total sales of $11.12 billion in the third quarter beat the Zacks Consensus Estimate of $11.06 billion by 0.6%. The top line also improved 6.7% from $10.42 billion in the year-ago quarter.

Grupo Aeromexico, S.A.B. de C.V. (AERO - Free Report) reported $1.62 billion in revenues in the third quarter of 2026, representing no change year over year. EPS was 28 cents compared with break-even earnings a year ago.

Reported revenues exceeded the Zacks Consensus Estimate of $1.61 billion by 0.62%. EPS missed the consensus mark of $0.29, delivering an average negative surprise of 3.45%.

30.10.2026 17:54

Index Dow Jones -0,87 % na 51887,04 b.
S&P 500 -1,8 % na 7581,78 b.
Nasdaq Composite -2,94 % na 25413,61 b.

Páteční obchodní den hlavní indexy klesají při pokračujícím výprodeji technologií. Tlak dolehl na čipový sektor, kde ztrácí Nvidia (- 4,56 %), Micron (- 5,8 %), anebo AMD (- 11,62 %). Intel odepisuje 29,9 % po reportu kvartálních výsledků po včerejším uzavření trhu. Uplynulý kvartál dosáhl na zisk na akcii ve výši 52 centů a slušně tak překonal analytické odhady. Tržby meziročně rostly o 21 % v souladu s odhadem. Vysoký meziroční růst tržeb o téměř 80 % dosáhla divize AI a služby datových center. Akcionáři negativně vnímají snížení dodávek počítačů, který meziročně poklesl o nízké jednotky procent. Pokles dodávek zesílilo i oslabení poptávky z důvodu zvyšujících se cen komponentů. Management očekává upravený zisk na akcii ve výši 25 centů a další zpomalování poptávky v první polovině příštího roku. Stranou se drží akcie Apple při poklesu o 0,5 %. Investoři ji považují za odpovědnější u kapitálových investic do rozvoje umělé inteligence.

Z indexu S&P 500 se nejlépe daří sektoru nezbytné spotřeby, do které se přelívají investice z rizikovějších odvětví a o jednotky procent rostou akcie Walmart, Colgante-Palmolive, anebo výrobců nápojů.

Amazon (- 2 %) reportoval dobré provozní výsledky. Tržby meziročně rostou o 12 % a provozní zisk vzrostl dokonce o víc než 60 %. Společnost tedy zlepšuje efektivitu. Podrobněji k výsledkům zde.

Astrazeneca plc roste o 7,5 % po potvrzení celoročního výhledu.  Tržby meziročně rostou o 7 % na USD 16,21 mld. Management hodlá zvýšit celoroční dividendu za rok 2026 na USD 3,3 a připravuje restrukturalizaci s cílem finančních úspor ve výši USD 1,5 mld. ročně.

V USA obchodované ADR BP plc rostou po výsledcích o desetiny procenta. Společnost reportovala silný kvartál s významným překonáním odhadů zisku na akcii ve výši USD 3,262. Část zisků pramení z vysoké rafinérské marže, která se do budoucna zřejmě sníží. Zadluženost společnosti klesla o USD 8,4 mld. na USD 13,87 mld. Silná čísla představil i Chevron (1,6 %), který těží z vysokých cen ropy. Upravený čistý zisk meziročně vzrostl o 185 % a společnosti se daří navyšovat produkci v USA. Ta se za dva roky zvýšila téměř o třetinu a očekává se další růst produkce například ve Venezuele, kde bude Chevron investovat jednotky miliard dolarů. Pokles čistého dluhu v Q3 dosáhl USD 7,8 mld.

Rivian Automotive reportoval nižší než očekávanou ztrátu, která přepočtena na akcii dosáhla 48 centů. Vedení automobilky současně vylepšilo celoroční výhled, kde předpokládá pro rok 26 dodání 67–70 tis. vozidel. Automobilová marže by se mohla dostat na kladnou hodnotu díky poklesu nákladů, které nadále zůstávají vysoké. Protivítr výrobce vidí i v rostoucích cenách komponentů pro výrobu. Cena akcie roste o 2,6 %.

Pokles dnes zaznamenává i kryptoměnový trh. Burzovně obchodované ETF fondy odepisují jednotky procent po bezpečnostním útoku na Binance, který podle předběžných informací vedl ke krádeži kryptoměn v objemu zhruba USD 6,3 mld. Spekuluje se o hackerském útoku vedeného z kompromitovaného zaměstnaneckého počítače.

Index S&P 500 -1,8 % na 7581,78 b.

Nejsilnější sektory S&P
Změna
Nejslabší sektory S&P
Změna

Nezbytná spotřeba
+1,8 %
Informační technologie
-4,5 %

Energie
+1,5 %
Průmysl
-1,2 %

Utility
+0,9 %
Zbytná spotřeba
-1,1 %

Nejsilnější akcie S&P
Změna
Nejslabší akcie S&P
Změna

Fedex Freight Holding (FDXF)
+14 %
Intel Corp (INTC)
-30 %

Regeneron Pharmaceuticals (REGN)
+11 %
Reddit (RDDT)
-30 %

Veralto Corp (VLTO)
+10 %
Illumina (ILMN)
-19 %

Global Payments (GPN)
+9,3 %
Twilio (TWLO)
-17 %

T-Mobile US (TMUS)
+7,5 %
Datadog (DDOG)
-14 %

Marek Kameništiak
Fio banka, a.s.
Prohlášení

Key Points:EUR/USD is losing ground as Germany's Inflation Rate falls to 2.8%. USD/CAD moves lower despite the strong sell-off in precious metals markets. USD/JPY pulls back as BoJ leaves rates unchanged.

U.S. Dollar Rebounds From Session Lows

DXY 301026 4h Chart U.S. Dollar Index gains some ground as traders focus on the rebound in Treasury yields. The yield of 2-year Treasuries climbed above the 4.61% level, while the yield of 10-year Treasuries settled near 4.95%. The sell-off in U.S. equity markets provided some support to U.S. dollar as demand for safe-haven assets increased.

U.S. Dollar Index failed to settle below the support level at 101.50 – 101.65 and rebounded towards the 50 MA at 101.92. In case U.S. Dollar Index settles above the 50 MA, it will head towards the nearest resistance, which is located in the 102.35 – 102.50 range. A successful test of this level will open the way to the test of the next resistance at 103.15 – 103.30.

EUR/USD Retreats As Germany’s Inflation Rate Drops To 2.8%

EUR/USD 301026 4h Chart EUR/USD pulled back despite the better-than-expected Euro Area GDP Growth Rate report. The report showed that Euro Area GDP Growth Rate was +1.3% in the third quarter, compared to analyst forecast of +1.1%.

Traders also had a chance to take a look at inflation data from Germany. Inflation Rate declined from 3.3% in September to 2.8% in October, compared to analyst forecast of 3%.

Currently, EUR/USD is trying to settle below the 1.1150 level. In case this attempt is successful, EUR/USD will head towards the next support, which is located in the 1.1100 – 1.1115 range.

GBP/USD Tests New Highs

GBP/USD 301026 4h Chart GBP/USD gains ground as rally continues. UK budget plan served as the key positive catalyst for the British pound.

From the technical point of view, GBP/USD attempts to settle above the resistance level at 1.3385 – 1.3400. In case GBP/USD manages to settle above the 1.3400 level, it will head towards the next resistance at 1.3485 – 1.3500. RSI is in the moderate territory, so there is plenty of room to gain momentum in the near term.

USD/CAD 301026 4h Chart USD/CAD remains under pressure despite the strong sell-off in precious metals markets. Gold is down by -3%, while silver pulled back by -5.6%. Other commodity-related currencies have also managed to gain some ground in today’s trading session.

EUR/USD Price Forecast

Every new EUR/USD analysis as it publishes, today's technical signal and key levels, live price — on one page.

See all EUR/USD forecasts If USD/CAD settles below the 1.3950 level, it will head towards the support level at 1.3900 – 1.3915. On the upside, a move above the resistance at 1.3985 – 1.4000 will push USD/CAD towards the 50 MA at 1.4018.

USD/JPY Pulls Back After BoJ Interest Rate Decision

USD/JPY 301026 4h Chart USD/JPY is losing some ground as traders react to BoJ Interest Rate Decision. The Bank of Japan left the interest rate unchanged at 1.25%, in line with analyst estimates.

Traders also had a chance to take a look at economic reports from Japan. Unemployment Rate declined from 2.5% in August to 2.4% in September, compared to analyst forecast of 2.5%.

Retail Sales increased by +2.3% year-over-year in September, compared to analyst consensus of +3.3%. Industrial Production grew by +2.2%, while analysts expected that it would increase by +1.3%. The report did not have a material impact on market dynamics as traders have mostly focused on BoJ decision.

Both Fed and BoJ decided to take a pause, and USD/JPY traders remained in wait-and-see mode. The Japanese yen remains fundamentally weak, but bulls are worried that BoJ may intervene in case USD/JPY climbs towards the 160.00 level.

In case USD/JPY stays below the 50 MA at 157.57, it will head towards the 157.00 level. A move below 157.00 will push USD/JPY towards recent lows near 156.00.

If you’d like to know more about how to trade forex, please visit our educational area.

Vladimir is an independent trader, with over 18 years of experience in the financial markets. His expertise spans a wide range of instruments like stocks, futures, forex, indices, and commodities, forecasting both long-term and short-term market movements.

Church & Dwight Company, Inc. (NYSE:CHD) stock climbed to a new 52-week high Friday after the ARM & HAMMER maker unveiled a $1 billion share buyback program, beat Wall Street's third-quarter earnings and revenue estimates and raised its full-year organic sales growth forecast.

In this video, I will cover SoFi's (SOFI -5.05%) latest earnings report and its first 2027 outlook, and explain why I will be buying more shares. Watch the short video to learn more, consider subscribing, and click the special offer link below.

Neil Rozenbaum has positions in SoFi Technologies. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. Neil is an affiliate of The Motley Fool and may be compensated for promoting its services. If you choose to subscribe through his link, he will earn some extra money that supports his channel. His opinions remain his own and are unaffected by The Motley Fool.

Key Takeaways Twilio's Q3 earnings beat estimates by 13%, while revenues surged 20% year over year to $1.56 billion.Messaging revenues rose 24%, while voice revenues grew more than 20% amid rising AI-related demand.TWLO raises its 2026 revenue growth outlook to 20% and projects at least $1.35B in 2027 free cash flow. Twilio Inc. (TWLO - Free Report) reported better-than-expected third-quarter 2026 results, with both earnings and revenues surpassing the Zacks Consensus Estimate. Non-GAAP earnings of $1.65 per share beat the consensus mark by 13%. The bottom line increased 32% from the year-ago quarter’s earnings of $1.25 per share, driven by robust revenue growth and operating leverage.

The cloud-based communications platform provider reported revenues of $1.56 billion, surpassing the consensus estimate by 3.1%. Revenues increased 20% year over year, driven by broad-based product strength and growing AI-related demand. The dollar-based net expansion rate was 114%, up from 109% a year ago.

TWLO's Q3 Revenue Growth DriversTwilio's organic revenues increased 16% year over year to $1.50 billion. Organic growth excludes incremental U.S. carrier pass-through fees and acquisition-related revenues. The company benefited from healthy demand across messaging, voice and software add-ons, alongside sustained momentum among AI-native customers.

Messaging revenues grew 24% year over year, supported by higher volumes and increased adoption of WhatsApp and Rich Communication Services. Incremental U.S. carrier fees contributed approximately seven percentage points to messaging revenue growth. Messaging accounted for 59% of total revenues during the quarter.

Voice revenues increased more than 20%, reflecting higher usage volumes and growing adoption of software add-ons. The self-serve channel registered revenue growth exceeding 30%, while independent software vendor revenues advanced more than 20%. Software add-on revenues grew more than 25%, and support and services revenues increased more than 30%.

Twilio's AI Momentum Supports Customer ExpansionTwilio witnessed continued adoption of its AI-enabled communications capabilities, including Conversation Relay, Conversational Intelligence and Branded Calling. Management highlighted growing demand from AI-native businesses deploying voice agents and expanding their usage across multiple communication channels.

The company secured several notable customer agreements during the quarter. Ushur signed a seven-figure expansion involving voice AI capabilities, while Gong renewed a seven-figure agreement. Twilio also secured its first eight-figure Conversations deal with a health insurance provider, underscoring growing enterprise interest in AI-powered customer engagement.

Management noted that voice AI represents approximately 1% of overall voice interactions, highlighting the early stage of adoption. Twilio is also developing identity verification capabilities for AI agents, with an offering currently in private beta and general availability planned for 2027.

TWLO's Profitability Improves Despite Carrier FeesNon-GAAP gross profit increased 18% year over year to $767.8 million. However, non-GAAP gross margin contracted 90 basis points year over year to 49.2%, primarily due to $53 million of incremental U.S. carrier pass-through fees. Excluding these fees, gross margin would have expanded 80 basis points.

Non-GAAP income from operations surged 39% year over year to $325.7 million. Non-GAAP operating margin expanded 290 basis points to approximately 21%, reflecting strong gross profit growth and cost efficiencies. Operating income benefited from approximately $11 million in platform credits.

Twilio's Cash Generation Remains StrongNet cash provided by operating activities reached $389.2 million compared with $263.6 million in the prior-year quarter. Free cash flow increased approximately 49% year over year to $369.6 million, with a free cash flow margin of 24%, up from 19%.

Twilio ended the third quarter with $1.06 billion in cash and cash equivalents and $1.83 billion in short-term marketable securities. Long-term debt stood at $993.6 million. The company repurchased $127.2 million of shares during the quarter, leaving approximately $700 million under its existing authorization.

TWLO Raises Its 2026 OutlookFor 2026, Twilio raised its reported revenue growth outlook to 20% from 18-18.5% and its organic revenue growth projection to 15% from 13-13.5%. The company also increased its non-GAAP income from operations and free cash flow guidance to $1.19-$1.20 billion each compared with the previous range of $1.135-$1.155 billion.

For the fourth quarter of 2026, Twilio expects revenues between $1.595 billion and $1.605 billion, indicating reported growth of 17-17.5% and organic growth of 11-12%. Non-GAAP income from operations is projected at $300-$310 million, with non-GAAP earnings of $1.48-$1.53 per share.

Twilio Provides an Upbeat 2027 Preliminary OutlookManagement expects organic revenue growth of at least 10% in 2027, exceeding its earlier long-term framework of 7-8%. Non-GAAP gross profit growth is anticipated to remain broadly aligned with organic revenue growth.

Twilio also projects non-GAAP income from operations and free cash flow of at least $1.35 billion each in 2027.

Twilio’s Zacks Rank & Other Stocks to ConsiderCurrently, TWLO carries a Zacks Rank #2 (Buy).

Some other top-ranked stocks in the broader Zacks Computer and Technology sector are Analog Devices (ADI - Free Report) , Autodesk (ADSK - Free Report) and Cisco Systems (CSCO - Free Report) , each carrying a Zacks Rank #2 at present. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Shares of Analog Devices have rallied 85.3% year to date. The Zacks Consensus Estimate for ADI’s fiscal 2026 earnings is pegged at $13.00 per share, up by 4 cents over the past 30 days, indicating an increase of 66.9% year over year.

Shares of Autodesk have plunged 19.6% year to date. The Zacks Consensus Estimate for ADSK’s fiscal 2027 earnings is pegged at $12.62 per share, unchanged over the past 30 days, indicating a rise of 21% year over year.

Cisco Systems shares have surged 50.5% year to date. The Zacks Consensus Estimate for CSCO’s fiscal 2027 earnings is pegged at $5.11 per share, unchanged over the past 30 days, indicating an increase of 18% year over year.

3 Top Stocks Under $20 Riding the “Made in America” WaveNewell Brands NASDAQ: NWL reported third-quarter 2026 sales growth that exceeded its guidance range, as broad-based market-share gains, product innovation and distribution expansion supported its second consecutive quarter of year-over-year revenue growth.

Net sales rose 3.7% to approximately $1.9 billion, while core sales increased 3.3%, above the company’s guided range of 2% to 3%. President and CEO Chris Peterson said growth extended across two of the company’s three segments, four of six businesses, seven of its top 10 brands and seven of its top 10 countries. The U.S. continued to grow, while international sales returned to growth, including positive core-sales performance in Latin America, EMEA and Asia-Pacific.

Get Newell Brands alerts:

Is Airbnb a buy on fee increase, international growth?“Top-line growth accelerated sequentially,” Peterson said, attributing the performance to investments in consumer insights, innovation, marketing and go-to-market capabilities.

Margins expand despite higher inflation
Newell’s normalized gross margin increased 70 basis points year over year to 35.2%, while normalized operating margin increased 90 basis points to 9.8%. CFO Mark Erceg said higher sales and productivity more than offset inflation and tariffs during the period. Normalized diluted earnings per share rose to $0.20 from $0.17 a year earlier.

Airbnb Joins the S&P 500, Time to Buy In? Trailing 12-month normalized EBITDA increased by approximately $173 million year over year to $1.03 billion. Net leverage declined to about 4.5 times, compared with 4.8 times at the end of the second quarter and 5.3 times a year earlier.

The company said inflation excluding tariffs continued to exceed expectations, led by diesel fuel, transportation, resins, purchased products and labor. Newell now expects a $220 million inflation headwind for 2026, up from an initial estimate of approximately $100 million at the start of the year. The projected amount represents about 4.6% of total cost of goods sold.

Peterson said Newell’s FUEL productivity program is expected to generate savings above its original budget and stretch target. The company has also used disciplined overhead management, higher sales and a portion of tariff refunds recorded in the second quarter to offset cost pressure. Limited pricing actions have covered less than 10% of the portfolio, according to management.

Growth across writing, home and commercial businesses
In Learning and Development, writing posted mid-single-digit core-sales growth, supported by what Peterson called the company’s strongest U.S. back-to-school point-of-sale growth in three years. Sharpie, EXPO, Elmer’s and Prismacolor benefited from innovation, distribution gains and replenishment orders.

Baby core sales were roughly flat, as U.S. growth was offset by lower Canadian sales. Graco delivered core-sales growth and continued gains in car seats, including its Turn2Me and EasyTurn 360 rotating-car-seat platforms. NUK also reported positive U.S. point-of-sale trends and market-share gains following its brand relaunch.

Home and Commercial core sales increased 6%, with all three businesses in the segment growing for the first time in five years. Commercial benefited from gains in U.S. business-to-business and do-it-yourself channels, while Kitchen delivered its second consecutive quarter of core-sales growth. Peterson cited demand for Rubbermaid Brilliance Glass Food Storage and growth from Crock-Pot design-series slow cookers.

Home Fragrance posted very strong core-sales growth against a favorable comparison. Yankee Candle returned to double-digit U.S. growth and gained market share, aided by retail-store, direct-to-consumer and grocery-channel performance.

Outdoor and Recreation core sales declined after returning to growth in the second quarter. Peterson described the result as largely a shipment-timing issue and said the company expects the business to return to positive core-sales growth in the fourth quarter. Contigo grew during the quarter, while Coleman Snap ’N Go coolers continued to see demand above initial expectations.

Updated outlook and 2027 pricing plans
For the fourth quarter, Newell expects net and core-sales growth of 1% to 3%, normalized operating margin of 8.4% to 9%, and normalized diluted EPS of $0.17 to $0.19.

The company raised its full-year sales outlook and now expects net-sales growth of 2% to 3% and core-sales growth of 1% to 2%. It maintained normalized operating-margin guidance of 10% to 10.4% and narrowed normalized diluted EPS guidance to $0.74 to $0.76, maintaining the $0.75 midpoint.

The earnings outlook includes approximately $100 million, or $0.17 per share, from a one-time recovery of IEEPA tariff costs expensed during 2025 and recognized in the second quarter of 2026.

For 2027, management said it is planning for approximately $150 million of inflation, lower than 2026 but still above normal levels. Newell expects to take modest pricing actions early in the year because productivity alone cannot fully offset the estimated two-year cumulative inflation impact of $370 million. Peterson said pricing would vary by business and geography and could include list-price adjustments, assortment changes, promotional actions and innovation-led pricing.

Management said baby gear could be excluded from some pricing actions if the U.S.-China “30-for-30” trade initiative results in lower tariffs for the category. Peterson said implementation details, timing and the extent of any tariff relief have not been confirmed.

Cash flow, refinancing and operations
Newell now expects approximately $150 million of full-year operating cash flow, down from a prior expectation of about $400 million. Erceg said the revision reflects cash-flow classification related to the termination of non-qualified defined-benefit plans and approximately $165 million less contribution from receivables factoring programs versus the prior year.

Management said the pension transaction is expected to provide a $60 million net cash benefit, although benefit payments and related taxes reduce reported operating cash flow by approximately $85 million. Newell continues to expect total debt and outstanding factored receivables combined to decline by a couple hundred million dollars from year-end 2025 and expects to finish 2026 comfortably below 4.5 times net leverage.

During the quarter, the company replaced its secured revolver with an $800 million asset-based revolving credit facility maturing in 2031. It also issued $600 million of 2031 senior notes with a 6.25% coupon, using proceeds to redeem June 2027 notes and repay revolving borrowings. Newell ended the quarter with no short-term debt outstanding.

The company also named Guillermo Beade as chief operating officer. Beade will lead global sales, central marketing and supply-chain functions.

About Newell Brands (NASDAQ:NWL)Newell Brands Inc is a global consumer products company that designs, manufactures and markets products used in homes, workplaces and outdoor settings. Its portfolio includes well-known brands such as Rubbermaid, Sharpie, Graco, Coleman, Yankee Candle, Crock-Pot, Mr. Coffee, FoodSaver, Calphalon, Elmer's and Sistema.

The company's products span food and home storage, cookware and small kitchen appliances, writing instruments and other learning supplies, baby and parenting products, outdoor and recreation equipment, home fragrance, and commercial products.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to [email protected].

Should You Invest $1,000 in Newell Brands Right Now?Before you consider Newell Brands, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Newell Brands wasn't on the list.

While Newell Brands currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The AI boom extends far beyond the biggest tech names. Discover 10 companies supplying the memory, storage, networking, semiconductor manufacturing, and power infrastructure that make AI possible. Learn where the next wave of AI investment opportunities may emerge—and the key risks investors should watch as the global AI buildout accelerates.

Get This Free Report

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Kevin O'Leary Says Bitcoin May Not 'Automatically' Rally Even If CLARITY Act Passes, Warns Midterms Could Create Washington 'Gridlock'

TAMPA, Fla.--(BUSINESS WIRE)---- $JOBY--Joby Aviation, Inc. (NYSE: JOBY) today launches a week of piloted electric air taxi flights across Florida, taking its aircraft from Tampa to Orlando and on to the Space Coast. The aircraft will fly at Orlando International Airport and Kennedy Space Center, helping map the first phase of Florida's planned Aerial Highway Network. These are Florida's first flights under the White House-backed eIPP program, announced by the U.S. Department of Transportation in March 2.

For the quarter ended September 2026, CBOE Global (CBOE - Free Report) reported revenue of $712.2 million, up 17.6% over the same period last year. EPS came in at $3.63, compared to $2.67 in the year-ago quarter.

The reported revenue represents a surprise of +0.99% over the Zacks Consensus Estimate of $705.22 million. With the consensus EPS estimate being $3.43, the EPS surprise was +5.83%.

While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.

Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.

Here is how CBOE performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:

Average Daily Volume by Product - Options - Index options: 6.05 million versus the five-analyst average estimate of 6.05 million.Average Revenue Per Contract by Product - Futures: $1.71 versus the five-analyst average estimate of $1.73.Average Revenue Per Contract by Product - Options - Index options: $0.95 compared to the $0.95 average estimate based on five analysts.Average Revenue Per Contract by Product - Options - Multiple - Listed Options: $0.05 versus $0.05 estimated by five analysts on average.Revenues- Access and capacity fees- Total: $120.4 million versus $117.25 million estimated by four analysts on average. Compared to the year-ago quarter, this number represents a +15.9% change.Revenues- Regulatory fees- Total: $155.5 million versus the four-analyst average estimate of $13.2 million. The reported number represents a year-over-year change of +1217.8%.Revenues- Market data fees- Total: $87.7 million compared to the $91.5 million average estimate based on four analysts. The reported number represents a change of +4.8% year over year.Revenues- Net transaction and clearing fees: $540.5 million versus the four-analyst average estimate of $536.98 million. The reported number represents a year-over-year change of +21%.Revenues- Other revenue- Total: $31.7 million versus the three-analyst average estimate of $24.53 million. The reported number represents a year-over-year change of +41.5%.Revenues- Net transaction and clearing fees- Global FX: $23.7 million versus the two-analyst average estimate of $23.53 million. The reported number represents a year-over-year change of +24.1%.Revenues- Data Vantage: $182.6 million versus the two-analyst average estimate of $181.86 million. The reported number represents a year-over-year change of +12.7%.Revenues- Net transaction and clearing fees- Futures: $20.5 million versus the two-analyst average estimate of $20.48 million. The reported number represents a year-over-year change of -8.5%.View all Key Company Metrics for CBOE here>>>

Shares of CBOE have returned +13.4% over the past month versus the Zacks S&P 500 composite's +0.7% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.

While the proven Zacks Rank places an emphasis on earnings estimates and estimate revisions to find strong stocks, we also know that investors tend to develop their own individual strategies. With this in mind, we are always looking at value, growth, and momentum trends to discover great companies.

Of these, value investing is easily one of the most popular ways to find great stocks in any market environment. Value investors use a variety of methods, including tried-and-true valuation metrics, to find these stocks.

On top of the Zacks Rank, investors can also look at our innovative Style Scores system to find stocks with specific traits. For example, value investors will want to focus on the "Value" category. Stocks with high Zacks Ranks and "A" grades for Value will be some of the highest-quality value stocks on the market today.

One stock to keep an eye on is Reinsurance Group of America (RGA - Free Report) . RGA is currently sporting a Zacks Rank #2 (Buy) and an A for Value. The stock is trading with P/E ratio of 7.54 right now. For comparison, its industry sports an average P/E of 10.92. Over the last 12 months, RGA's Forward P/E has been as high as 10.24 and as low as 7.17, with a median of 8.48.

We should also highlight that RGA has a P/B ratio of 1.02. Investors use the P/B ratio to look at a stock's market value versus its book value, which is defined as total assets minus total liabilities. This stock's P/B looks solid versus its industry's average P/B of 2.30. Over the past year, RGA's P/B has been as high as 1.47 and as low as 0.96, with a median of 1.18.

Value investors also use the P/S ratio. The P/S ratio is calculated as price divided by sales. This is a popular metric because sales are harder to manipulate on an income statement, so they are often considered a better performance indicator. RGA has a P/S ratio of 0.66. This compares to its industry's average P/S of 0.8.

These figures are just a handful of the metrics value investors tend to look at, but they help show that Reinsurance Group of America is likely being undervalued right now. Considering this, as well as the strength of its earnings outlook, RGA feels like a great value stock at the moment.

Key Takeaways Cullen/Frost lifts 2026 NII, average loan growth and noninterest income forecasts on stronger momentum.Loan growth, Texas expansion, improving margins and rising fee income support its upgraded outlook.Higher operating expenses and potential commercial credit deterioration could challenge earnings growth. Cullen/Frost Bankers (CFR - Free Report) raised its full-year 2026 outlook following strong third-quarter results, reflecting confidence in its operating momentum and organic growth strategy. Management increased its expectations for net interest income (NII), average loan growth and noninterest income, supported by strong loan demand, expanding customer relationships and improving net interest margins (NIM). The bank's continued expansion across Texas and growth in fee-generating businesses are also contributing to its performance.

However, rising operating expenses and credit costs could weigh on profitability, raising questions about how much of this growth momentum will translate into sustainable earnings improvement.

CFR Raises 2026 Outlook: What's Behind the Optimism?Management raised its full-year 2026 guidance across three key revenue and growth metrics, reflecting stronger-than-anticipated business momentum. The company now expects NII growth of 5-5.5%, up from its previous projection of 4.75-5.25%. Its average loan growth outlook has been raised to 8-8.5% from 7-8%, while the forecast for noninterest income growth has been increased to 8.5-9% from 7.5-8.5%.

Meanwhile, management maintained its expectation for a 10-13-basis-point improvement in NIM in 2026 over the 2025 level and average deposit growth of 2-3% year over year in 2026.

The upward revisions reflect stronger loan volumes, favorable revenue trends and continued investments in organic expansion.

Factors Supporting CFR's Growth MomentumLoan Growth and Texas Expansion: Cullen/Frost's average loans increased 7.4% year over year to $22.7 billion in the first nine months of 2026, while average deposits rose 2.3% to $42.8 billion. Its Texas expansion continued to support growth, with expansion branches recording 40% loan growth and 23% deposit growth year over year as of September 2026-end. 

Commercial momentum remained strong, with the bank adding more than 1,000 new relationships in the third quarter, 21% of which came from expansion markets. Continued investment across Texas is expected to support customer acquisition, lending and deposit growth.

Improvement in NII and Margins: Cullen/Frost's NII recorded a 12.2% compound annual growth rate (CAGR) during 2020-2025. In the first nine months of 2026, taxable-equivalent NII increased 5.3% year over year to $1.42 billion, while net interest income to average earning assets improved to 3.76% from 3.65%. NIM increased to 3.76% in the first nine months of 2026 from 3.65% in the year-ago period, supported by lower average funding costs and higher average loan and tax-exempt securities volumes. Taxable-equivalent net interest income rose 5.3% year over year to $1.42 billion. However, lower average loan yields and higher volumes of interest-bearing deposits and repurchase agreements partly offset these benefits. Going forward, sustained loan growth, a favorable earning-asset mix and disciplined funding-cost management will remain important to supporting net interest income growth.

Fee Income Diversification: Cullen/Frost is expanding its fee-based businesses to diversify revenues. Noninterest income increased 9.2% year over year to $400.6 million in the first nine months of 2026. Trust and investment management fees rose 10.4% to $145.1 million, while deposit service charges increased 15% to $102.6 million. Continued growth in wealth management, insurance and deposit services should strengthen fee income and reduce reliance on interest revenue.

Can CFR Sustain Growth?Despite Cullen/Frost's upward guidance revisions, rising expenses remain a concern. Noninterest expenses increased 5.4% year over year to $1.10 billion in the first nine months of 2026, driven by higher salaries, employee-related costs, advertising and technology expenses. Management expects full-year 2026 noninterest expense growth of approximately 5% over 2025 level. 

Nevertheless, strong loan growth, improving margins, expanding customer relationships and higher fee income are expected to support future performance. The Zacks Consensus Estimate for 2026 earnings and revenues calls for year-over-year growth of 10.17% and 5.46%, respectively.

Earnings and Sales Estimates 

Image Source: Zacks Investment Research

Sustaining this momentum will depend on the bank's ability to convert its growing pipeline into funded loans, maintain margin improvement and generate consistent fee income while keeping expenses and credit costs under control.

Shares of CFR have rallied 24.6% year to date against the industry’s 0.1% decline.

Image Source: Zacks Investment Research

Currently, the company carries a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

2026 Outlook of Other BanksRegions Financial (RF - Free Report) and Texas Capital Bancshares (TCBI - Free Report) outlined their 2026 outlooks, emphasizing revenue growth, expense discipline and balance-sheet optimization.

Regions Financial expects 2026 NII to grow 2.5-4% from $4.99 billion in 2025. Adjusted noninterest income is projected to rise 3-5%, while adjusted noninterest expenses may increase 1.5-3.5%. Average loans and deposits are expected to grow at low-single-digit rates, with net charge-offs at 40-50 basis points of average loans, trending toward the lower end. Management also expects to generate positive adjusted operating leverage.

Texas Capital Bancshares expects adjusted total revenues to grow at a high-single-digit rate in 2026, compared with adjusted revenues of $1.26 billion in 2025. Full-year noninterest income is projected at $295-$300 million, while noninterest expenses are expected to increase 6.6%-7.2% year over year. Management also expects positive operating leverage, supported by continued fee growth and disciplined expense management.

Sprouts Farmers Market, Inc. plummeted after the company reported a double miss for Q3. Comparable store sales are trending downward, ultimately also questioning SFM's margin level. The Q4 guidance suggests very sharp weakness ahead. Competitive intensity seems to be eroding SFM's earnings power.

It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different ways to do both.

The research service features daily updates of the Zacks Rank and Zacks Industry Rank, full access to the Zacks #1 Rank List, Equity Research reports, and Premium stock screens, all of which will help you become a smarter, more confident investor.

Zacks Premium includes access to the Zacks Style Scores as well.

What are the Zacks Style Scores? The Zacks Style Scores, developed alongside the Zacks Rank, are complementary indicators that rate stocks based on three widely-followed investing methodologies; they also help investors pick stocks with the best chances of beating the market over the next 30 days.

Each stock is assigned a rating of A, B, C, D, or F based on their value, growth, and momentum characteristics. Just like in school, an A is better than a B, a B is better than a C, and so on -- that means the better the score, the better chance the stock will outperform.

The Style Scores are broken down into four categories:

Value ScoreValue investors love finding good stocks at good prices, especially before the broader market catches on to a stock's true value. Utilizing ratios like P/E, PEG, Price/Sales, Price/Cash Flow, and many other multiples, the Value Style Score identifies the most attractive and most discounted stocks.

Growth ScoreGrowth investors are more concerned with a stock's future prospects, and the overall financial health and strength of a company. Thus, the Growth Style Score analyzes characteristics like projected and historic earnings, sales, and cash flow to find stocks that will see sustainable growth over time.

Momentum ScoreMomentum traders and investors live by the saying "the trend is your friend." This investing style is all about taking advantage of upward or downward trends in a stock's price or earnings outlook. Employing factors like one-week price change and the monthly percentage change in earnings estimates, the Momentum Style Score can indicate favorable times to build a position in high-momentum stocks.

VGM ScoreWhat if you like to use all three types of investing? The VGM Score is a combination of all Style Scores, making it one of the most comprehensive indicators to use with the Zacks Rank. It rates each stock on their combined weighted styles, which helps narrow down the companies with the most attractive value, best growth forecast, and most promising momentum.

How Style Scores Work with the Zacks Rank The Zacks Rank, which is a proprietary stock-rating model, employs earnings estimate revisions, or changes to a company's earnings expectations, to make building a winning portfolio easier.

It's highly successful, with #1 (Strong Buy) stocks producing an unmatched +23.82% average annual return since 1988. That's more than double the S&P 500. But because of the large number of stocks we rate, there are over 200 companies with a Strong Buy rank, plus another 600 with a #2 (Buy) rank, on any given day.

But it can feel overwhelming to pick the right stocks for you and your investing goals with over 800 top-rated stocks to choose from.

That's where the Style Scores come in.

To maximize your returns, you want to buy stocks with the highest probability of success. This means picking stocks with a Zacks Rank #1 or #2 that also have Style Scores of A or B. If you find yourself looking at stocks with a #3 (Hold) rank, make sure they have Scores of A or B as well to ensure as much upside potential as possible.

Since the Scores were created to work together with the Zacks Rank, the direction of a stock's earnings estimate revisions should be a key factor when choosing which stocks to buy.

Here's an example: a stock with a #4 (Sell) or #5 (Strong Sell) rating, even one with Style Scores of A and B, still has a downward-trending earnings outlook, and a bigger chance its share price will decrease too.

Thus, the more stocks you own with a #1 or #2 Rank and Scores of A or B, the better.

Stock to Watch: Urban Outfitters (URBN - Free Report) Urban Outfitters, Inc. was founded in 1970 and is headquartered in Philadelphia, PA. It is a lifestyle products and services company that sells fashion apparel, accessories, footwear, home goods and related offerings through a portfolio of global consumer brands. The company’s key brands include Anthropologie, Free People, FP Movement, Urban Outfitters and Nuuly. Anthropologie also includes the Terrain and Maeve brands. Free People also includes FP Movement. The company operates in North America and Europe, and also sells through franchise partners in the Middle East.

URBN is a #2 (Buy) on the Zacks Rank, with a VGM Score of A.

Additionally, the company could be a top pick for growth investors. URBN has a Growth Style Score of A, forecasting year-over-year earnings growth of 14% for the current fiscal year.

One analyst revised their earnings estimate higher in the last 60 days for fiscal 2027, while the Zacks Consensus Estimate has increased $0.04 to $6.20 per share. URBN also boasts an average earnings surprise of +9.7%.

With a solid Zacks Rank and top-tier Growth and VGM Style Scores, URBN should be on investors' short list.

, /PRNewswire/ -- The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Hims & Hers Health, Inc. (NYSE: HIMS) securities between August 4, 2025 and July 29, 2026, all dates inclusive (the "Class Period"), have until this Monday, November 2, 2026 to seek appointment as lead plaintiff of the Hims & Hers class action lawsuit. Captioned Velanki v. Hims & Hers Health, Inc., No. 26-cv-09313 (N.D. Cal.), the Hims & Hers class action lawsuit charges Hims & Hers as well as certain of Hims & Hers' executives with violations of the Securities Exchange Act of 1934.

If you suffered substantial losses and wish to serve as lead plaintiff of the Hims & Hers class action lawsuit, please provide your information here:

https://www.rgrdlaw.com/cases-hims-hers-health-class-action-lawsuit-hims.html

You can also contact attorneys Ken Dolitsky or Michael Albert of Robbins Geller by calling 800/851-7783 or via e-mail at [email protected].

CASE ALLEGATIONS: Hims & Hers operates as a health and wellness platform that connects consumers to licensed healthcare professionals.

The Hims & Hers class action lawsuit alleges that defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that: (i) Hims & Hers shared consumers' health information with third-party advertising platforms; (ii) Hims & Hers charges consumers for prescriptions almost immediately after they submit an intake form, despite telling consumers that they will be able to consult with a medical provider to find a treatment that is "right for them"; (iii) the foregoing conduct subjected Hims & Hers to regulatory scrutiny; (iv) as a result of the foregoing, Hims & Hers was reasonably likely to incur fees and penalties; and (v) as a result of the foregoing, defendants' positive statements about Hims & Hers' business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

On July 29, 2026, the Federal Trade Commission allegedly announced it had filed a lawsuit against Hims & Hers "alleging that the telehealth provider shared consumers' sensitive health information about medical conditions with third-party advertising platforms despite claiming its services maintain consumers' privacy and deceives users about its billing and cancellation practices." The Hims & Hers class action lawsuit further alleges that, according to the Federal Trade Commission's complaint, Hims & Hers engages in other deceptive advertising practices, including failing to "clearly disclose that it charges consumers for prescriptions almost immediately after they submit an intake form, despite telling consumers that they will be able to consult with a medical provider to find a treatment that is 'right for them.'" Additionally, the Hims & Hers class action lawsuit alleges that the Federal Trade Commission's complaint includes allegations that Hims and Hers "shared consumers' sensitive health information with third-party advertising companies and platforms . . . such as Meta Platforms, Inc. ('Meta') and Snap Inc. ('Snap')." On this news, the price of Hims and Hers shares declined nearly 15%, according to the complaint.

THE LEAD PLAINTIFF PROCESS: The Private Securities Litigation Reform Act of 1995 permits any investor who purchased or acquired Hims & Hers securities during the Class Period to seek appointment as lead plaintiff in the Hims & Hers class action lawsuit. A lead plaintiff is generally the movant with the greatest financial interest in the relief sought by the putative class who is also typical and adequate of the putative class. A lead plaintiff acts on behalf of all other class members in directing the Hims & Hers class action lawsuit. The lead plaintiff can select a law firm of its choice to litigate the Hims & Hers class action lawsuit. An investor's ability to share in any potential future recovery is not dependent upon serving as lead plaintiff of the Hims & Hers class action lawsuit.

ABOUT ROBBINS GELLER: Robbins Geller Rudman & Dowd LLP is one of the world's leading law firms representing investors in securities fraud and shareholder rights litigation. Our Firm ranked #1 on the most recent ISS Securities Class Action Services Top 50 Report, recovering more than $916 million for investors in 2025. This marks our fourth #1 ranking in the past five years. And in those five years alone, Robbins Geller recovered $8.4 billion for investors – $3.4 billion more than any other law firm. With 200 lawyers in 10 offices, Robbins Geller is one of the largest plaintiffs' firms in the world, and the Firm's attorneys have obtained many of the largest securities class action recoveries in history, including the largest ever – $7.2 billion – in In re Enron Corp. Sec. Litig. Please visit the following page for more information:

https://www.rgrdlaw.com/services-litigation-securities-fraud.html

Past results do not guarantee future outcomes.
Services may be performed by attorneys in any of our offices. 

Contact:
          Robbins Geller Rudman & Dowd LLP
          Ken Dolitsky
          Michael Albert
          655 W. Broadway, Suite 1900, San Diego, CA 92101
          800/851-7783
          [email protected] 

SOURCE Robbins Geller Rudman & Dowd LLP